DK139029C - - Google Patents

Info

Publication number
DK139029C
DK139029C DK318177A DK318177A DK139029C DK 139029 C DK139029 C DK 139029C DK 318177 A DK318177 A DK 318177A DK 318177 A DK318177 A DK 318177A DK 139029 C DK139029 C DK 139029C
Authority
DK
Denmark
Application number
DK318177A
Other languages
Danish (da)
Other versions
DK318177A (xx
DK139029B (da
Inventor
C A Lipinski
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of DK318177A publication Critical patent/DK318177A/da
Publication of DK139029B publication Critical patent/DK139029B/da
Application granted granted Critical
Publication of DK139029C publication Critical patent/DK139029C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK318177AA 1976-07-16 1977-07-13 Analogifremgangsmåde til fremstilling af 5-m-tolyloxyuracil. DK139029B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (3)

Publication Number Publication Date
DK318177A DK318177A (xx) 1978-01-17
DK139029B DK139029B (da) 1978-12-04
DK139029C true DK139029C (xx) 1979-05-07

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK318177AA DK139029B (da) 1976-07-16 1977-07-13 Analogifremgangsmåde til fremstilling af 5-m-tolyloxyuracil.

Country Status (29)

Country Link
US (1) US4080454A (xx)
JP (1) JPS5337673A (xx)
AR (1) AR213652A1 (xx)
AT (1) AT351561B (xx)
BE (1) BE856710A (xx)
CA (1) CA1061788A (xx)
CH (1) CH622512A5 (xx)
CS (1) CS212264B2 (xx)
DD (1) DD131556A5 (xx)
DE (1) DE2731736A1 (xx)
DK (1) DK139029B (xx)
EG (1) EG12762A (xx)
ES (1) ES460686A1 (xx)
FI (1) FI772183A (xx)
FR (1) FR2358399A1 (xx)
GB (1) GB1542178A (xx)
GR (1) GR68686B (xx)
HU (1) HU177713B (xx)
IL (1) IL52409A (xx)
LU (1) LU77764A1 (xx)
NL (1) NL7707729A (xx)
NO (1) NO772489L (xx)
PH (1) PH13190A (xx)
PL (1) PL103783B1 (xx)
PT (1) PT66808B (xx)
SE (1) SE421125B (xx)
SU (1) SU673169A3 (xx)
YU (1) YU171677A (xx)
ZA (1) ZA773927B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
NZ565955A (en) 2005-08-22 2011-08-26 Melior Pharmaceuticals I Inc Methods and formulations for modulating lyn kinase activity and treating related disorders
KR20100014480A (ko) * 2007-02-20 2010-02-10 멜리어 파마슈티칼스 아이, 인코포레이티드 Lyn 키나제 활성제의 확인 방법
NZ579288A (en) * 2007-07-23 2012-06-29 Melior Discovery Inc Methods of activating irs-1 and akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
NZ758966A (en) 2017-04-10 2024-08-30 Board Of Supervisors Of Louisiana State Univ And Agricultural And Mechanical College Treatment of adipocytes
AU2019223911A1 (en) 2018-02-21 2020-07-23 Melior Pharmaceuticals I, Inc. Treatment of liver diseases

Also Published As

Publication number Publication date
SE7707471L (sv) 1978-01-17
AU2663877A (en) 1978-05-18
DD131556A5 (de) 1978-07-05
SE421125B (sv) 1981-11-30
IL52409A0 (en) 1977-08-31
FR2358399A1 (fr) 1978-02-10
FI772183A (xx) 1978-01-17
YU171677A (en) 1982-06-30
PH13190A (en) 1980-01-16
NO772489L (no) 1978-01-17
JPS5337673A (en) 1978-04-06
PL103783B1 (pl) 1979-07-31
BE856710A (fr) 1978-01-11
GR68686B (xx) 1982-02-01
PL199633A1 (pl) 1978-04-10
ES460686A1 (es) 1978-12-01
CH622512A5 (xx) 1981-04-15
PT66808A (en) 1977-08-01
SU673169A3 (ru) 1979-07-05
IL52409A (en) 1979-11-30
FR2358399B1 (xx) 1980-10-17
AR213652A1 (es) 1979-02-28
DE2731736A1 (de) 1978-01-26
HU177713B (en) 1981-12-28
GB1542178A (en) 1979-03-14
EG12762A (en) 1979-12-31
ZA773927B (en) 1978-05-30
US4080454A (en) 1978-03-21
DK318177A (xx) 1978-01-17
NL7707729A (nl) 1978-01-18
AT351561B (de) 1979-08-10
CA1061788A (en) 1979-09-04
LU77764A1 (xx) 1978-02-02
ATA509277A (de) 1979-01-15
DK139029B (da) 1978-12-04
CS212264B2 (en) 1982-03-26
JPS5512017B2 (xx) 1980-03-29
PT66808B (en) 1978-12-21

Similar Documents

Publication Publication Date Title
JPS5611588B2 (xx)
JPS5630698Y2 (xx)
CS173369B1 (xx)
CH599828A5 (xx)
CH613068A5 (xx)
BG23302A1 (xx)
BG23395A1 (xx)
BG23397A1 (xx)
BG23414A1 (xx)
BG23458A1 (xx)
BG23474A2 (xx)
CH592988A5 (xx)
CH593248A5 (xx)
CH593347A5 (xx)
CH593485A5 (xx)
CH594276A5 (xx)
CH595819A5 (xx)
CH596023A5 (xx)
CH597877A5 (xx)
CH598474A5 (xx)
CH598518A5 (xx)
CH598848A5 (xx)
CH599781A5 (xx)
BG23276A1 (xx)
CH600316A5 (xx)